Label: MAGNESIUM OXIDE tablet
- NDC Code(s): 24689-132-01
- Packager: APNAR PHARMA LP
- Category: HUMAN OTC DRUG LABEL
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Updated July 29, 2022
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
- ACTIVE INGREDIENT
- INDICATIONS & USAGE
Ask a doctor before use if you have kidney disease
Ask a doctor or pharmacist before use if you are taking a prescription drug. Antacid may interact with certain prescription drugs.
Do not take more than 2 tablets in a 24 hour period or use the maximum dosage of this product for more than two weeks, except under the advice and supervision of a physician
If pregnant or breast-feeding, ask a professional before use
- KEEP OUT OF REACH OF CHILDREN
- DOSAGE & ADMINISTRATION
- STORAGE AND HANDLING
- INACTIVE INGREDIENT
- SPL UNCLASSIFIED SECTION
- PRINCIPAL DISPLAY PANEL
INGREDIENTS AND APPEARANCE
magnesium oxide tablet
Product Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:24689-132 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength MAGNESIUM OXIDE (UNII: 3A3U0GI71G) (MAGNESIUM CATION - UNII:T6V3LHY838) MAGNESIUM OXIDE 400 mg Inactive Ingredients Ingredient Name Strength SILICON DIOXIDE (UNII: ETJ7Z6XBU4) STEARIC ACID (UNII: 4ELV7Z65AP) CROSCARMELLOSE SODIUM (UNII: M28OL1HH48) MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) STARCH, CORN (UNII: O8232NY3SJ) Product Characteristics Color white (White to off white) Score 2 pieces Shape ROUND (Round shaped standard concave) Size 11mm Flavor Imprint Code AM3 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:24689-132-01 120 in 1 BOTTLE; Type 0: Not a Combination Product 08/05/2022 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part331 08/05/2022 Labeler - APNAR PHARMA LP (079568229) Establishment Name Address ID/FEI Business Operations INVAHEALTH INC 116840615 pack(24689-132) , label(24689-132) Establishment Name Address ID/FEI Business Operations APNAR PHARMA LLP 118530917 manufacture(24689-132) , analysis(24689-132) , pack(24689-132)